TRANSCEND SARCOMA
The objects of the CIO areFor the public benefit the relief of sickness and the preservation ofhealth in particular by providing grants to fund medical researchinto Soft Tissue Sarcoma, specifically those Sarcomas caused bychromosomal translations, and by promoting and supporting thepublication and dissemination of the useful results of suchresearch.
Objects
THE OBJECTS OF THE CIO ARE:FOR THE PUBLIC BENEFIT THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH IN PARTICULAR BY PROVIDING GRANTS TO FUND MEDICAL RESEARCH INTO SOFT TISSUE SARCOMA, SPECIFICALLY THOSE SARCOMAS CAUSED BY CHROMOSOMAL TRANSLATIONS, AND BY PROMOTING AND SUPPORTING THE PUBLICATION AND DISSEMINATION OF THE USEFUL RESULTS OF SUCH RESEARCH.
Financial health, per its FY2025 accounts
The charity reported a net surplus of £53,841.40 for the year ended 30 June 2025, with total income of £86,725.91 and total expenditure of £32,884.51. The trustees confirmed the charity has sufficient resources to continue in operational existence for the foreseeable future, maintaining a positive cash position. The charity holds unrestricted reserves of £53,841.40, which it retains to support future grant-making and provide a working capital buffer.
What the accounts disclose
“As a voluntary-run organisation with minimal overhead costs, the trustees do not consider it necessary to maintain reserves based on a fixed number of months of operating expenditure.” — page 8
Policies the charity declares
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
Trustees
- Assad Rashid ACA
- Harry Fothergill
- Mark Holmes
- Rachel Louise Kapo
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £87k | £33k |
Common questions
Is TRANSCEND SARCOMA financially healthy?
Per its FY2025 accounts: The charity reported a net surplus of £53,841.40 for the year ended 30 June 2025, with total income of £86,725.91 and total expenditure of £32,884.51. The trustees confirmed the charity has sufficient resources to continue in operational existence for the foreseeable future, maintaining a positive cash position. The charity holds unrestricted reserves of £53,841.40, which it retains to support future grant-making and provide a working capital buffer. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE CATHERINE COOKSON CHARITABLE TRUST | 2 | £22k |
| THE ALICE ELLEN COOPER-DEAN CHARITABLE FOUNDATION | 1 | £45k |
| BONE CANCER RESEARCH TRUST | 1 | £43k |
| THE RANDAL CHARITABLE FOUNDATION | 1 | £41k |
| THE EMMANUEL KAYE FOUNDATION | 1 | £35k |
| THE WATSON FAMILY CHARITABLE TRUST | 1 | £30k |
| ROBERT LUFF FOUNDATION LIMITED | 1 | £30k |
| THE LENNOX HANNAY CHARITABLE TRUST | 1 | £25k |
Charities like this
- THE EDWARD SHOWLER FOUNDATION
- SARCOMA UK
- BRITISH LYMPHOLOGY SOCIETY
- RESTORATION CHURCH ROTHERHAM
- THE DORCAS DRESS PROJECT
- JESSICA'S SARCOMA AWARENESS
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| TRANSCEND SARCOMA | £87k | — | — | unclear | — | no doubt |
| THE EDWARD SHOWLER FOUNDATION | £144k | — | 0 | unclear | — | no doubt |
| SARCOMA UK | £4.6m | — | — | above | 26.0% | no doubt |
| BRITISH LYMPHOLOGY SOCIETY | £270k | — | — | above | — | no doubt |
| RESTORATION CHURCH ROTHERHAM | £45k | — | — | unclear | — | no doubt |
| THE DORCAS DRESS PROJECT | £60k | — | 0 | unclear | — | no doubt |